.png){kind=icon}
-
Healthcare
Commercialization
-
Analysis Services
Bioanalytical Services Drug Metabolism and Pharmacokinetics (DMPK) StudiesSafety Assessment and Drug Safety Testing
General Toxicology Studies Genetic Toxicology Immunotoxicology Nonclinical Pathology Services Safety Pharmacology Services Developmental and Reproductive Toxicology (DART) Studies SEND - Standard for the Exchange of Nonclinical Data -
Consulting & Partnering
Alliance Management Early Phase Development Solutions Covance MarketPlace Drug Development Consulting Access & Strategy Evidence GenerationClinical Development
Early Clinical / Phase IIa Phase IIb / III Services Drug Life Cycle Management Clinical Data Management Analysis and Reporting Regulatory ServicesInformatics
Xcellerate® Trial Design Xcellerate® Trial Management Xcellerate® Monitoring Xcellerate® Insights GlobalCODE® -
Clinical Testing
Flow Cytometry Solutions Central Laboratory Services Translational Biomarkers & Diagnostics Companion Diagnostics Genomics Solutions Expanded Lab Management Solutions Vaccines & Novel ImmunotherapeuticsFunctional Service Provision (FSP)
Commercialization
Covance Market Access Patient Support Field ServicesManufacturing Support
Biopharm CMC Solutions
-
Media Relations
Request an InterviewRequest a SpeakerInvestigators
Kit OrderingInvestors
Investor RelationsJob Seekers
Covance Careers -
General Contact Information
The Americas
+1.888.COVANCE (+1.888.268.2623)1.609.452.4440Europe/Africa
+00.800.2682.2682+44.1423.500888Asia/Pacific
+800.6568.3000+65.6.5686588Global Office Locations
-
Sales and Current Customers
Drug Development Sales InquiryFood Solutions Sales InquiryResearch Models InquirySuppliersClinical Trials
Participate in a Clinical Trial
Copyright © 2018 Covance Inc. All rights reserved.
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.